Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole

A Phase 2, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail

(2020) B. Elewski et al.   BRITISH JOURNAL OF DERMATOLOGY

Onychomycosis: a review

(2020) Aditya K. Gupta et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient

(2020) Ahmad Nofal et al.   Dermatologic Therapy

A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis

(2020) Stephen R Brand et al.   CLINICAL INFECTIOUS DISEASES

The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses

(2020) Aditya K. Gupta et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study

(2018) Shinichi Watanabe et al.   JOURNAL OF DERMATOLOGY

Antifungal resistance in dermatology

(2018) Varadraj Pai et al.   INDIAN JOURNAL OF DERMATOLOGY

Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis

(2015) E. P. Garvey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

(2015) E. P. Garvey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole Treatment of Extensive Skin and Nail Dermatophytosis Due to Autosomal Recessive Deficiency of CARD9

(2015) Marie Jachiet et al.   JAMA Dermatology

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

(2014) A. G. S. Warrilow et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanisms of Antifungal Drug Resistance

(2014) Leah E. Cowen et al.   Cold Spring Harbor Perspectives in Medicine

Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis

(2013) Seyedmojtaba Seyedmousavi et al.   Expert Review of Anti-Infective Therapy

Case Report of Exposure to Voriconazole in the Second and Third Trimesters of Pregnancy

(2012) M. Shoai Tehrani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

(2011) B. Elewski et al.   BRITISH JOURNAL OF DERMATOLOGY

Skin Concentrations and Pharmacokinetics of Posaconazole after Oral Administration

(2010) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY